420 Results (Page 1 of 17)
Japan Markets Research Reports
Japan Basal Cell Carcinoma Therapeutics Market Analysis
Japan Basal Cell Carcinoma Therapeutics market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. The most typical type of skin cancer and the most typical type of cancer overall is basal cell carcinoma (BCC). Rarely can basal cell carcinoma appear in mucous membranes; it typically appears on sun-damaged skin. The market for Basal Cell Carcinoma Therapeutics is being driven by an increase in the occurrence of skin cancers and better treatment options. The high cost of care and basal cell carcinoma's high propensity for underdiagnosis, however, are anticipated to impede the market's expansion. The high cost of care and basal cell carcinoma's high propensity for underdiagnosis, however, are anticipated to impede the market's expansion. Companies like MedC Biopharma Corporation, AiViva BioPharma, MediWound, Kintara Therapeutics, IO Biotech, Sirnaomics, Aresus Pharma, Epitome Pharmaceuticals, Transgene, Senhwa Biosciences, Palvella Therapeutics, Suzhou Kintor Pharmaceuticals, Leaf Vertical, and others are active in the basal cell carcinoma market.
Japan Healthcare Diagnostics Market Analysis
This report presents a strategic analysis of the Japan Healthcare Diagnostics Market and a forecast for its development in the medium and long term. It provides a broad overview of the market dynamics, trends and insights, growth drivers and restraints, segmentation, competitive landscape, healthcare policies and regulatory framework, reimbursement scenario, challenges and future outlook. This is one of the most comprehensive reports about the Japan Healthcare Diagnostics Market, offering unmatched value, accuracy and expert insights.
Japan Morquio Syndrome (MPS-IV) Therapeutics Market Analysis
Japan Morquio Syndrome (MPS-IV) Therapeutics Market is projected to grow from $xx Mn in 2023 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2023 ? 2030. As genetic illnesses like Morquio Syndrome (MPS-IV) has become more common, there is an increasing demand for specialised drugs to treat them. Major global players in Morquio Syndrome (MPS-IV) Therapeutics Market are BioMarin, Genzyme Corporation, Shire, JCR Pharmaceuticals Co., Ltd., Sanofi, Sangamo Therapeutics, ArmaGen and GREEN CROSS CORP, Concert Pharmaceuticals Inc., Alexion Pharmaceuticals Inc., and other players.
Japan Brain Cancer Therapeutics Market
Japan Brain Cancer Therapeutics Market valued at $143 Mn in 2022, projected to reach $332 Mn by 2030 with a 11.1% CAGR. The expected rise in instances of brain cancer, specifically glioblastoma multiforme, is projected to significantly enhance the demand for therapies aimed at treating brain cancer, thereby influencing the overall structure of the market. Top leading pharmaceutical companies presently operating in the market are Roche, Novartis, Pfizer, Merck, AstraZeneca, Bristol Myers Squibb, Eli Lilly, Sanofi, Johnson & Johnson and Takeda.
Japan Alzheimer’s Therapeutics Market Analysis
Japan alzheimer’s therapeutics market valued at $298 Mn in 2022, projected to reach $621 Mn by 2030 with a 9.6% CAGR. The growing prevalence of Alzheimer's disease, which is fuelled by an aging population, is one major factor driving the market for drugs used to treat the condition. The leading pharmaceutical companies currently operating in the market are Eisai, Otsuka Holdings Co., Astellas Pharma Inc., Mitsubishi Tanabe Pharma Corporation, Sumitomo Dainippon Pharma Co., Takeda Pharmaceutical Company, Roche Holding, Novartis, Pfizer, and Lundbec.
Japan Electronic Health Records Market Analysis
Japan's electronic health record market size was valued at $2.26 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4% from 2022 to 2030 and will reach $3.09 Bn in 2030. Japan's EHR market growth can be attributed to the increasing adaptation of EHR by hospitals and clinics. The market is segmented by product type, application type, and end user. The key market players are Ujitsu, NEC, M3, NTT Data, and others.
Japan Infectious Disease Drugs Market Analysis
Japan Infectious Disease Drugs Market valued at $7.38 Bn in 2023, projected to reach $10.23 Bn by 2030 with a 4.77% CAGR. Rising healthcare expenditure, government initiatives and funding, and technological advancements in drug development are driving the market. The market is dominated by key players like Takeda Pharmaceuticals, Daiichi Sankyo, AbbVie Inc., Gilead Sciences, Merck & Co., F. Hoffman-La Roche Ltd., GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, and Novartis AG.
Japan Atopic Dermatitis Therapeutics Market Analysis
The Japan Atopic Dermatitis Therapeutics Market was valued at US $77 Mn in 2022, and is predicted to grow at (CAGR) of 9.3% from 2023 to 2030, to US $1.56 Bn by 2030. The key drivers of this industry include the increasing disease burden of Atopic Dermatitis (AD), growing healthcare spending, and an evolving treatment landscape. The industry is primarily dominated by players such as Otsuka, Maruho, Tanabe, Fuji Film, Sanofi, Novartis, Mitsubishi, and AbbVie, among others.
Japan Atherosclerosis Therapeutics Market Analysis
Japan Atherosclerosis Therapeutics Market was valued at $174 Mn in 2022 and is estimated to reach $282 Mn in 2030, exhibiting a CAGR of 6.2% during the forecast period. The demand for atherosclerosis treatments is expected to rise due to the growing cases of cardiovascular diseases, escalated by unhealthy eating habits, inactive lifestyles, and a globally aging population. The top leading pharmaceutical companies presently operating in the industry are Novartis, Eisai, AstraZeneca, Pfizer, Mitsubishi Tanabe Pharma Corporation, Merck Sharp & Dohme, Sanofi, Bayer, Daiichi Sankyo and Takeda Pharmaceutical Company.
Japan Asthma and COPD Therapeutics Market Analysis
The Japan Asthma and COPD Therapeutics Market was valued at US $2.076 Bn in 2022, and is predicted to grow at (CAGR) of 5.70% from 2023 to 2030, to US $3.235 Bn by 2030. The key drivers of this industry include the surge in the prevalence of COPD and Asthma, supportive government initiatives, advancements in technology, and others. The industry is primarily dominated by players such as AstraZeneca, Novartis, Daiichi Sankyo, Chugai, Sumitomo, and Mochida, among others.
Japan HIV Drugs Market Analysis
Japan HIV Drugs Market is at around $1.97 Bn in 2023 and is projected to reach $2.61 Bn in 2030, exhibiting a CAGR of 4.1% during the forecast period. The market is growing as a result of government initiatives, rising HIV prevalence, and the expansion of healthcare infrastructure. The market is dominated by key players like Takeda Pharmaceutical Company, Eisai Co., Ltd., Daiichi Sankyo Company, Limited, Gilead Sciences, ViiV Healthcare, Boehringer Ingelheim International GmbH, Janssen Pharmaceuticals, Merck & Co., Bristol-Myers Squibb, AbbVie Inc., and F. Hoffmann-La Roche Ltd.
Japan Antifungal Drugs Market Analysis
Japan Antifungal Drugs Market is at around $0.98 Bn in 2023 and is projected to reach $1.33 Bn in 2030, exhibiting a CAGR of 4.3% during the forecast period. The market is expanding due to rising healthcare costs, the prevalence of risk factors, and technological advancements. The market is dominated by key players like Merck & Co., Pfizer Inc., Novartis AG, Abbott Laboratories, Astellas Pharma Inc., GlaxoSmithKline plc, Bayer AG, Glenmark Pharmaceuticals Limited, Sanofi S.A., and Gilead Sciences Inc.
Japan Pharmaceutical Drugs Delivery Market Analysis
Japan Pharmaceutical Drugs Delivery market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Drugs Delivery is growing rapidly as a result of increase in prevalence of chronic diseases, desire for healthcare systems to focus more on advanced drug delivery technologies, growing emphasis on product safety, efficacy and patient-friendliness, increasing investment for healthcare infrastructure, growing geriatric population and the need for enhanced therapeutic outcomes. Johnson & Johnson, Pfizer Inc, Novartis AG, GlaxoSmithKline plc, Roche Holding AG, AstraZeneca plc, Merck & Co., Inc, Sanofi S.A. are the key market players operating globally.
Japan Pharmaceutical Excipient Market Analysis
Japan Pharmaceutical Excipient market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Excipient is growing rapidly as a result of growing Pharmaceutical Industry, Generic Drug Production driven by patent expiration and cost considerations, drug delivery systems advncements like such as controlled-release formulations, nanoparticles, and transdermal patches, requires specialized excipients to achieve the desired drug release profiles. Kerry Group plc., DFE Pharma, Cargill, Incorporated, Pfanstiehl, Colorcon, MEGGLE GmbH & Co. KG, Omya AG, Peter Greven GmbH & Co. KG, Ashland., Evonik, Dow, Croda International Plc, Roquette Frères., The Lubrizol Corporation, BASF SE, Avantor, Inc., BENEO, Chemie Trade are the key global market players.
Japan Pharmaceutical Filtration Market Analysis
Japan Pharmaceutical Filtration Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Filtration is growing rapidly as a result of increase in biopharmaceutical production, factors including the rising demand for high-quality pharmaceutical products, stringent regulatory standards, need to decrease illnesses linked to healthcare, rising demand for ultrafiltration track-etched membranes and increasing usage of single-use technologies. Merck KGaA, Pall Corporation (Danaher Corporation), Sartorius AG, GE Healthcare, 3M Company, Parker Hannifin Corporation, Eaton Corporation, Amazon Filters Ltd., Meissner Filtration Products Inc., Graver Technologies are the key global market players in Pharmaceutical Filtration market.
Japan Pharmaceutical Packaging Market Analysis
Japan Pharmaceutical Packaging Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical packaging is growing rapidly as a result of increased demand for drug delivery systems such as prefilled syringes, autoinjectors, transdermal patches and inhalers requiring specialized packaging solutions to ensure proper dosing, administration and product stability, regulatory compliance and safety to ensure product safety, integrity, packaging which must protect against contamination, requirement of counterfeit and tamper resistance packaging and increase in need of blister packaging. Amcor plc, West Pharmaceutical Services, Inc., Schott AG, Gerresheimer AG, Berry Global Inc., AptarGroupInc., Owens-Illinois, Inc., Becton, Dickinson and Company (BD), Constantia Flexibles Group GmbH and WestRock Company are the key global market players in pharmaceutical packaging market.
Japan Pharmaceutical Robots Market Analysis
Japan Pharmaceutical Robots Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for pharmaceutical robots is rising due to increasing number of medical research activities, increased emphasis on efficiency and productivity of pharmaceuticals. Kawasaki Heavy Industries Ltd. (Japan), FANUC Corporation (Japan), KUKA AG (Germany), Mitsubishi Electric Corporation (Japan), ABB (Switzerland), Denso corporation (Japan), etc. are some of the key players in this market.
Japan Pharmaceutical Solvent Market Analysis
Japan Pharmaceutical Solvent Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Pharmaceutical Solvent is rising due to increase in demand for solvent in vaccines and medicines, expansion of the pharmaceutical industry, development of novel drug formulations and growing research and development activities. Some of the major players operating in the global pharmaceutical solvent market are Royal Dutch Shell Plc, BASF SE, Brenntag SE, Merck KGaA, Dow, DuPont, LyondellBasell Industries Holdings B.V., Exxon Mobil Corporation, Clariant AG, and Mitsui Chemicals.
Japan Pharmaceutical Waste Management Market Analysis
Japan Pharmaceutical Waste Management Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The global pharmaceutical waste management market is growing due to increase in the amount of waste generated by pharmaceutical and healthcare companies globally. Quick rise in the patient population and increasing awareness related to adverse effect on environment caused by these companies. Additionally, many federal bodies maintain laws related to medical waste, these consist of the Occupational Safety and Health Administration (OSHA), the Drug Enforcement Administration (DEA), Centers for Disease Control (CDC). Sharps Compliance, Inc., Waste Management, Inc., Clean Harbours, Inc., Remondis Se & Co. Kg, Biomedical Waste Solutions, LLC, Daniels Sharpsmart, Inc., and Republic Services, Inc. are just a few of the companies that participate in this industry.
Japan Pharmacovigilance & Drugs Safety Software Market Analysis
Japan Pharmacovigilance & Drugs Safety Software Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pharmacovigilance & Drugs Safety Software Market is growing due to the increasing volume and complexity of drug safety data, stringent regulatory requirements and the need for efficient adverse event reporting and management. The market for drug safety solutions and pharmacovigilance is primarily driven by the increasing frequency of adverse drug reactions (ADRs). Additionally, tight government restrictions for drug development before and after commercialization as well as outsourcing firms growing use of pharmacovigilance software all contribute to the market's expansion. Drug safety solutions, pharmacovigilance automation research partnerships and integration of systems of pharmacovigilance software with electronic health records (EHRs), clinical trial management systems and regulatory databases also are all anticipated to have a positive impact on the market. IQVIA, Accenture, Cognizant, Laboratory Corporation of America Holdings, IBM, ArisGlobal, ICON Plc., Capgemini, Oracle, Parexel International Corporation are the key global market players in Pharmacovigilance & Drugs Safety Software Market.
Japan Pharmacy Market Analysis
Japan Pharmacy Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pharmacy market is growing due to the increasing number of people suffering from diseases, increasing aging population, growing number of prescriptions and technological advancements like electronic health records (EHRs), pharmacy automation systems, medication dispensing technologies, medication therapy management (MTM) platforms and digital health solutions like E- pharmacy which offer advantages including privacy and confidentiality, free shipping, savings, a shorter purchase process, and a variety of deals. Additionally, it is predicted that the increased use of digital technology by the healthcare sector, rising smartphone penetration, and rising numbers of retailers launching online channels would all contribute to the segment's growth. CVS Health, Boots Walgreens, Cigna, Walmart, Kroger, Rite Aid Corp., Lloyd Pharmacy, Well Pharmacy, Humana Pharmacy Solutions and Matsumoto Kiyoshi are the key global market players in pharmacy market.
Japan Photorejuvenation Market Analysis
Japan Photorejuvenation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Photorejuvenation market is expected to grow because of Increasing personal disposable income, growing number of skin surgeries, increasing consumer awareness about aesthetic procedures, a growing aging population and increasing prevalence of skin problems among people such as Acne, Birthmarks, fine wrinkles, and scars are formed due to the blocking of the tiny holes in the skin, overgrowth of blood vessels, the breakdown of collagen and elastin in the skin and tissue damage due to the body's natural healing process. Hologic Inc. (Cynosure, Inc.) Lumenis Syneron, Medical Ltd., Lynton Lasers Ltd, EL.EN. S.p.A. (Deka Mela S.r.l.), Fotona Cutera Inc., Lutronic Corporation, Beijing Nubway S & T Co., Ltd, LISA Laser Products are the key global market players in photorejuvenation market.
Japan Phycocyanin Market Analysis
Japan Phycocyanin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Phycocyanin market is growing globally due to the growth and expansion of the food and beverage industry, the food and beverage sector's increasing focus on innovations, consumers' growing awareness of the benefits of consuming foods and beverages high in protein and other nutrients, the accelerating rate of the use of food additives and colorants, and rising personal disposable income.
Japan Pigments Market Analysis
Japan Pigments Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Pigments market is growing globally due to the increasing demand from end use industries like paints and coatings, automotive, plastics, construction, textiles, growing construction and infrastructure development, technological advancements in pigments manufacturing like nanotechnology and availability of products on e-commerce platforms. The Chemours Company, Huntsman Corporation, Tronox Holdings plc, Sun Chemical Corporation, Clariant Corporation, LANXESS Corporation, Kronos Worldwide, Inc., PPG Industries, Inc., Ferro CorporationAmerican Colors, Inc. are the key global market players in pigments market.
Japan Plasma Protease C1-inhibitor Market Analysis
Japan Plasma Protease C1-inhibitor Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The market for Plasma Protease C1-inhibitor is growing due to increasing product approvals, rising research and development, increase in incidence and prevalence of hereditary angioedema (HAE), a rare genetic condition brought on by a C1-inhibitor deficit or malfunction, Increase in diagnosis of HAE, improvements in available medicines, and the launch of novel therapies. Takeda Pharmaceutical Company, CSL Behring, Pharming Group NV, Ionis pharmaceuticals, BioCryst pharmaceuticals and kalvista pharmaceuticals are the key global market players in Plasma Protease C1-inhibitor Market.